US 9,518,083 B2Granted

Gadd45beta targeting agents

AssigneeImperial Innovations Limited

InventorsGuido Franzoso, Albert Andrzej Jaxa-Chamiec, Caroline Minli Rachel Low, Simona Maria Monti, Menotti Ruvo, Laura Tornatore, Catherine Jane Tralau-Stewart

Life of this patent

Estimating the term…

Abstract

Compounds based around tetrapeptide, tripeptide and dipeptide moeties and corresponding peptiod moeties. Related methods and pharmaceutical compositions for use in treatment of cancer, inflammatory diseases, and other disorders.

Claims2

Dependent claims

A compound according to Formula I

or a pharmaceutically acceptable salt thereof.

Dependencies are inferred from the claim text.

Facts

Application: 14/618,613Filed 10 Feb 2015 · continuation
Priority: GB 0918579422 Oct 2009
Published: US 2015/0368294 A124 Dec 2015
Granted: 13 Dec 2016
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

C07K 5/08
Containing only normal peptide links: tripeptides
A61P 35/00
Antineoplastic agents
C07K 5/06078
With the first amino acid being neutral: and aromatic or cycloaliphatic
C07K 5/06104
Dipeptides: with the first amino acid being acidic

Family

PCT/GB2010/001970Parent of this continuation · filed 22 Oct 2010
US 2015/0368294 A1Pre-grant publication · published 24 Dec 2015
Application13/502,781Parent of this continuation
US 8,993,717 B2Parent of this continuation
US 2012/0277164 A1Published application
US 9,518,083 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results